{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:39:15Z","timestamp":1773481155584,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":346,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.7861\/clinmed.2023-0137","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T17:25:33Z","timestamp":1685121933000},"page":"271-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Valproate-induced hyperammonemic encephalopathy treated by L-ornithine-L-aspartate: a case report"],"prefix":"10.1016","volume":"23","author":[{"given":"Yan","family":"Yu-E","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Zhi-Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zheng-Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2023-0137_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.7861\/clinmed.2023-0137_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/appi.ajp.2019.18040363","article-title":"Fulminant onset of valproate-associated hyperammonemic encephalopathy","volume":"176","author":"Baumgartner","year":"2019","journal-title":"Am J Psychiatry"},{"key":"10.7861\/clinmed.2023-0137_bib4","doi-asserted-by":"crossref","first-page":"217269","DOI":"10.1155\/2014\/217269","article-title":"Hyperammonaemia associated with valproic acid concentrations","volume":"2014","author":"Vazquez","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.7861\/clinmed.2023-0137_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/ajp.2007.164.7.1020","article-title":"Hyperammonaemia due to valproic acid in the psychiatric setting","volume":"164","author":"Carr","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.7861\/clinmed.2023-0137_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: Carnitine in the treatment of valproic acid induced toxicity - what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care"},{"key":"10.7861\/clinmed.2023-0137_bib8","doi-asserted-by":"crossref","first-page":"107967","DOI":"10.1016\/j.yebeh.2021.107967","article-title":"Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment","volume":"120","author":"Wu","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.7861\/clinmed.2023-0137_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/hep.510300311","article-title":"L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure","volume":"30","author":"Rose","year":"1999","journal-title":"Hepatology"},{"key":"10.7861\/clinmed.2023-0137_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.genhosppsych.2019.05.005","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","volume":"59","author":"Duman","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"key":"10.7861\/clinmed.2023-0137_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.inoche.2007.10.024","article-title":"Unprecedented sodium-oxygen clusters in the solid-state structure of trisodium hydrogentetravalproate monohydrate: A model for the physiological activity of the anticonvulsant drug Epilim\u00ae","volume":"11","author":"Petrusevski","year":"2008","journal-title":"Inorg Chem Commun"},{"key":"10.7861\/clinmed.2023-0137_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.jcp.0000264973.77581.61","article-title":"Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy","volume":"27","author":"Nicolai","year":"2007","journal-title":"J Clin Psychopharmacol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2023-0137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:51:01Z","timestamp":1744447861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824046165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1470211824046165"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2023-0137","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate-induced hyperammonemic encephalopathy treated by L-ornithine-L-aspartate: a case report","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2023-0137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2023. All rights reserved.","name":"copyright","label":"Copyright"}]}}